HLA-E and neoplasm: Tumor cells upregulate their surface expression of inhibitory ligands such as CD111 [104], CD112 [105,106], CD155 [106,107], CD200 [108], PD-L1 [109,110], HLA-E [111], and HLA-G [112,113].